- Status:
- Red
- Decision Date:
- September 2019
Comments
RED:
- NICE TA595: untreated EGFR mutation-positive non-small-cell- lung cancer.
NHS England drug. To be used in line with NHSE commissioning intentions.
Red Drug Classifications
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again
